Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1), Ast...
- Telphone : +1 (905) 787-2041
- Email Address: [email protected]
iHealth Solutions - Moving Forward
Moving Forward